Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation
Crossref DOI link: https://doi.org/10.1007/s13277-015-3249-x
Published Online: 2015-02-22
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fiala, Ondrej
Pesek, Milos
Finek, Jindrich
Minarik, Marek
Benesova, Lucie
Bortlicek, Zbynek
Topolcan, Ondrej
Text and Data Mining valid from 2015-02-22